Objective To investigate the expression of nm23-H1 in epithelial ovari
an cancer. Methods A total of 55 specimens from patients with epitheli
al ovarian cancers, 15 patients with serous cancers, 7 with mucinous c
ancers, 17 with endometriord cancers and 16 with adenocarcinomas, were
examined for the expression of nm23-H1 by means of the immunohistoche
mical technique. Results The total positive rate was 23.64% (13/55). T
he tissular nm23-H1 immunostaining had significantly higher expression
in mucinous cancer (57.14%) than in other histologic types of epithel
ial ovarian cancer (P<0.05). Compared to that in the primary tumor, nm
23-H1 expression in the omental metastatic tumor in the same patient w
as reduced. Conclusions The expression rate of nm23-H1 is higher in th
e primary tumors than in the metastatic tumors and is different in var
ious histologic subtypes of epithelial ovarian cancer. The expression
of nm23-H1 may participate in the inhibitory process of tumor invasion
.